A study led by researchers at Warwick Medical School could help thousands of headache sufferers by investigating whether a new education and self-management programme will help improve their quality of life.

Warwick Medical School is starting a trial to improve the lives of long-term strong painkiller users.

Congratulations to the Warwick Clinical Trials Unit PARAMEDIC2 Trial Team, who have won the West Midlands Clinical Research Network (CRN) Team of the Year Award for greatest contribution to research in the West Midlands.

Professor Gavin Perkins will become the new Director of Warwick Clinical Trials Unit (CTU) from 1 October 2017. He was appointed after an international search and it is a source of great pride for us that Gavin, who is already an established member of CTU, was the best candidate for this key post in the Medical School.

The University of Warwick is to receive more than £7 million to find better ways of delivering healthcare to some of the world’s poorest people.

Warwick Medical School were delighted to host the annual Society for Academic Primary Care conference on the 12th, 13th and 14th July in the Ramphal Building.

A researcher from Warwick Medical School is one of a European team who have developed an online tool and an app for predicting the chance of women developing persistent pain after breast cancer surgery.

Dr Harbinder Sandhu talks about the WCTU's I-WOTCH study, looking at reducing patients' use of opioids - strong pain relief medication.

Researchers at WMS have opened a window of opportunity for physiotherapists to influence future investigations into fragility fractures in people over 60.

Prof Gavin Perkins has been published in NEJM for his paper on Levosimendan for the Prevention of Acute Organ Dysfunction in Sepsis. Levosimendan is a calcium-sensitizing drug with inotropic and other properties that may improve outcomes in patients with sepsis.

How is a Warwick Clinical Trial and Strictly Come Dancing connected?

Well done to the MAMMO 50 trial team who have successfully randomised 2500 patients. This target takes them to the halfway stage!

Ankile Injury Rehabilitation trial has reached its recruitment target! Further details on the trial can be found here

Head and neck cancer patients may no longer have to undergo invasive post-treatment surgery to remove remaining cancer cells, as research shows that innovative scanning-led surveillance can help identify the need for, and guidance of, neck dissection.